State-of-the-art facilities to future-proof biotech manufacturing

future-proof biotech

Manufacturers’ Monthly spoke with CSL Limited about its new manufacturing facilities, COVID-19, and its exciting plans for local manufacturing of advanced vaccines and other biotech products.   Given the events of 2020 and 2021, it is plain to everyone the imperative of ensuring Australia improves its sovereign research and manufacturing capabilities in the domain of biotechnology.   CSL […]

This website uses cookies to ensure you get the best experience on our website.